EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitKohortenstudie

Adult‐onset linear IgA bullous dermatosis: a retrospective single‐center cohort study of 81 patients and literature review

Katherine L Wang iD, Julia S Lehman, Austin Todd, Dawn M R Davis iD

International Journal of Dermatology · 2024

DOI: 10.1111/ijd.17041 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Katherine L Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic Alix School of Medicine, Mayo Clinic, Jacksonville, FL, USA. Hauptthemen laut MEDLINE: Linear IgA Bullous Dermatosis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Linear IgA bullous dermatosis (LABD) is a rare autoimmune blistering disorder that may be drug‐induced or paraneoplastic. We aim to characterize features of LABD and determine differentiating factors among idiopathic, drug‐induced, or malignancy‐associated diseases.

Methods

We conducted a single‐center retrospective chart review of adult patients with linear IgA bullous dermatosis at a large tertiary referral center and a literature review of adult linear IgA bullous dermatosis.

Results

Eighty‐one patients were included in the study. Ten patients (12.3%) had comorbid malignancy and nine (11.1%) had inflammatory bowel disease. Median disease duration was significantly shorter in both drug‐induced (1.2 vs. 48.8 months; P < 0.001) and malignancy‐associated (1.7 vs. 48.8 months; P < 0.001) LABD compared with idiopathic LABD. Recurrent episodes occurred significantly more often in idiopathic LABD compared to those with drug‐induced (76.1 vs. 11.5%; P < 0.001) or malignancy‐associated disease (76.1 vs. 33.3%; P = 0.019). Time to diagnosis was significantly shorter in the drug‐induced (0.2 vs. 5.4 months; P < 0.001) and malignancy‐associated groups (0.7 vs. 5.4 months; P = 0.049) compared with idiopathic; similarly, time to improvement was significantly shorter in both drug‐induced (0.4 vs. 3.0 months; P < 0.001) and malignancy‐associated disease (1.1 vs. 3.0 months; P = 0.016). Clinical morphology was indistinguishable between groups. Limitations included retrospective data collection, data from tertiary referral centers, and limited racial and ethnic diversity.

Conclusion

Screening for underlying malignancy, as well as for a predisposing medication or possibly inflammatory bowel disease, may be advisable in patients with LABD, particularly when it is newly diagnosed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Linear IgA Bullous DermatosisAdultFemaleHumansMaleAge of OnsetDrug EruptionsInflammatory Bowel DiseasesNeoplasmsParaneoplastic SyndromesRecurrenceRetrospective Studies

Autor:innen und Institutionen

  • Mayo Clinic Alix School of Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.
  • Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.

ORCID-Profile: Katherine L Wang, Dawn M R Davis

Zitieren

APA

Wang, K. L., Lehman, J. S., Todd, A., & Davis, D. M. R. (2024). Adult‐onset linear IgA bullous dermatosis: a retrospective single‐center cohort study of 81 patients and literature review. International Journal of Dermatology. https://doi.org/10.1111/ijd.17041

Vancouver

Wang KL, Lehman JS, Todd A, Davis DMR. Adult‐onset linear IgA bullous dermatosis: a retrospective single‐center cohort study of 81 patients and literature review. International Journal of Dermatology. 2024. doi:10.1111/ijd.17041

BibTeX
@article{Wang2024,
  author = {Wang, Katherine L and Lehman, Julia S and Todd, Austin and Davis, Dawn M R},
  title = {Adult‐onset linear IgA bullous dermatosis: a retrospective single‐center cohort study of 81 patients and literature review},
  journal = {International Journal of Dermatology},
  year = {2024},
  doi = {10.1111/ijd.17041}
}
Kostenlos starten →